|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
IsoRay, Inc. (ISR) Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer
11/8/2010 10:12:50 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (Amex: ISR) announced, today, it has been awarded $526,910 under the IRS Qualifying Therapeutic Discovery Program (QTDP). Created by Congress, the program is part of the Patient Protection and Affordable Care Act of 2010. The QTDP provides financial support for innovative projects that the U.S. Department of Health and Human Services believes could well result in a new therapy, reduce health care costs, or represent an important advance in finding a cure for cancer.
|
|
|
|
|
|
|
|
|
|
|